Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Excess graft losses in adolescent recipients of living donor (LD) renal transplants (TX): A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Excess graft losses in adolescent recipients of living donor (LD) renal transplants (TX): A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Evaluation of pre- and post transplant DST/CsA in non-HLA identical living donor kidney transplant recipients.

Go back to Resources

Evaluation of pre- and post transplant DST/CsA in non-HLA identical living donor kidney transplant recipients.

Authors:

Location:

Go back to Resources

Sensitivity with specificity of a screening questionnaire for dry eye,

Go back to Resources

Sensitivity with specificity of a screening questionnaire for dry eye,

Authors:

Go back to Resources

Sample-path insensitivity of symmetric queues in discrete-time.

Go back to Resources

Sample-path insensitivity of symmetric queues in discrete-time.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety profile of Phase I and II preventive HIV tTpe 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group,

Go back to Resources

Safety profile of Phase I and II preventive HIV tTpe 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 104
  • Page 105
  • Page 106
  • Page 107
  • Current page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions